Immuno-Oncology

Technology and expertise for clinical success.
Upcoming Conference: Connect with us at AACR Annual Meeting, April 1-5
NEW THERAPIES FOR PRECISION MEDICINE

Design Successful Immunotherapies

Over 800 immuno-oncology clinical trials are ongoing. What will make yours successful?

Understanding Patient Response to Immune Modulating Drugs

  • Create the enabling data needed to make critical decisions about your therapeutic strategy
  • Personalize immunotherapies for the best patient response
  • Determine patient selection strategies for drug combinations
  • Improve clinical strategies by leveraging basket and adaptive trial designs
  • Engage in novel biomarker strategies while ensuring regulatory compliance
  • Determine the most rational clinical trial strategy for success
INCREASE SENSITIVITY, PRECISION, AND ACCURACY

Understand Biomarker Content with the Benefit of Tissue Context

Flagship’s cTA™ platform reports the biologically relevant phenotypes which captures your drugs mechanism of action.

Explore New Opportunities in Tissue Data

Measure the immune contexture to find the robust, actionable data needed for decision making.

Flagship’s scientific team leverages our whole slide image analysis technology to meet your I/O drug development needs

Accelerate Your I/O Drug Development

Develop a biomarker strategy to better understand drug mechanisms.

Improve clinical strategies by targeting responsive patients.

Create a successful diagnostic strategy to predict patient outcome.

Differentiate your drug successfully with actionable biological data.

SOLVE DIFFICULT TISSUE ANALYSIS CHALLENGES WITH OUR UNIQUE APPROACH

Work With Us

Breadth and depth in people and technology to deliver on any challenge
Work With Us